Skip to main content
TipRanks
Go Ultimate75% OFF

Richard Pascoe Insider Profile

4 Followers

Richard Pascoe, Director at Seelos Therapeutics, holds 29.97K shares in Zevra Therapeutics (Ticker: ZVRA), holds 30.00K shares in Histogen (Ticker: HSTOQ), holds 155.40K shares in Seelos Therapeutics (Ticker: SEELQ). Most recently, Richard Pascoe Bought ― shares of Zevra Therapeutics on Mar 13, 2023 for an estimated value of $41.90K.

Richard Pascoe's Trading History

ZVRA
Zevra Therapeutics
Mar 13, 2023CEO, DirectorInformative Buy41.90K$272.15K
HSTOQ
Histogen
Mar 30, 2021―Informative Buy22.80K$330.00
SEELQ
Seelos Therapeutics
Jan 24, 2019DirectorUninformative Sell9.86K―
SOMX
Somaxon Pharmaceuticals
――――
~ARIA
Ariad
―――$0.00

You May Also Like

Richard Pascoe insider profile FAQ

What is the percentage of profitable transactions made by Richard Pascoe?
The percentage of profitable transactions made by Richard Pascoe is 50%.
What is the average return per transaction made by Richard Pascoe?
The average return per transaction made by Richard Pascoe is -9.70%.
What stocks does Richard Pascoe hold?
Richard Pascoe holds: SEELQ, HSTOQ, ZVRA, ~ARIA, SOMX stocks.
What was Richard Pascoe’s latest transaction?
Richard Pascoe’s latest transaction was an Informative Buy of $41.90K.
What was Richard Pascoe's most profitable transaction?
Richard Pascoe’s most profitable transaction was an Informative Buy of ZVRA stock on March 13, 2023. The return on the trade was 41.40%.
What is Richard Pascoe's role in Seelos Therapeutics?
Richard Pascoe's role in Seelos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.